Omnicell Total Liabilities 2010-2024 | OMCL
Omnicell total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Omnicell Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $1,038 |
| 2022 | $1,081 |
| 2021 | $996 |
| 2020 | $857 |
| 2019 | $396 |
| 2018 | $402 |
| 2017 | $462 |
| 2016 | $503 |
| 2015 | $176 |
| 2014 | $170 |
| 2013 | $144 |
| 2012 | $134 |
| 2011 | $81 |
| 2010 | $78 |
| 2009 | $80 |
| Omnicell Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,072 |
| 2024-06-30 | $1,089 |
| 2024-03-31 | $1,095 |
| 2023-12-31 | $1,038 |
| 2023-09-30 | $1,034 |
| 2023-06-30 | $1,030 |
| 2023-03-31 | $1,108 |
| 2022-12-31 | $1,081 |
| 2022-09-30 | $1,044 |
| 2022-06-30 | $1,039 |
| 2022-03-31 | $1,048 |
| 2021-12-31 | $996 |
| 2021-09-30 | $940 |
| 2021-06-30 | $908 |
| 2021-03-31 | $876 |
| 2020-12-31 | $857 |
| 2020-09-30 | $801 |
| 2020-06-30 | $335 |
| 2020-03-31 | $353 |
| 2019-12-31 | $396 |
| 2019-09-30 | $437 |
| 2019-06-30 | $424 |
| 2019-03-31 | $447 |
| 2018-12-31 | $402 |
| 2018-09-30 | $433 |
| 2018-06-30 | $438 |
| 2018-03-31 | $466 |
| 2017-12-31 | $462 |
| 2017-09-30 | $451 |
| 2017-06-30 | $460 |
| 2017-03-31 | $471 |
| 2016-12-31 | $503 |
| 2016-09-30 | $504 |
| 2016-06-30 | $500 |
| 2016-03-31 | $513 |
| 2015-12-31 | $176 |
| 2015-09-30 | $185 |
| 2015-06-30 | $202 |
| 2015-03-31 | $165 |
| 2014-12-31 | $170 |
| 2014-09-30 | $168 |
| 2014-06-30 | $160 |
| 2014-03-31 | $145 |
| 2013-12-31 | $144 |
| 2013-09-30 | $148 |
| 2013-06-30 | $138 |
| 2013-03-31 | $136 |
| 2012-12-31 | $134 |
| 2012-09-30 | $125 |
| 2012-06-30 | $117 |
| 2012-03-31 | $83 |
| 2011-12-31 | $81 |
| 2011-09-30 | $81 |
| 2011-06-30 | $78 |
| 2011-03-31 | $78 |
| 2010-12-31 | $78 |
| 2010-09-30 | $78 |
| 2010-06-30 | $77 |
| 2010-03-31 | $81 |
| 2009-12-31 | $80 |
| 2009-09-30 | $79 |
| 2009-06-30 | $75 |
| 2009-03-31 | $71 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.826B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Enovis (ENOV) | United States | $2.544B | 16.95 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| 10x Genomics (TXG) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |